cholesteryl ester transfer protein: at the heart of the action of lipid-modulating therapy with...

Cholesteryl ester transfer protein: at the heart of the action of lipid-modulating therapy with statins, fibrates, niacin,

and cholesteryl ester transfer protein inhibitors

by M. John Chapman, Wilfried Le Goff, Maryse Guerin, and Anatol Kontush

EHJVolume 31(2):149-164

January 14, 2010

Published on behalf of the European Society of Cardiology. All rights reserved. © The Author 2009. For permissions please email: journals.permissions@oxfordjournals.org

Pathways of reverse cholesterol transport in man.

M. John Chapman et al. Eur Heart J 2010;31:149-164

Published on behalf of the European Society of Cardiology. All rights reserved. © The Author 2009. For permissions please email: journals.permissions@oxfordjournals.org

Comparison of pathways of cholesteryl ester transfer protein-mediated heterotransfer of neutral core lipids between lipoprotein particles in normotriglyceridaemia vs. mixed dyslipidaemia involving moderate to marked hypertriglyceridaemia and subnormal levels of triglyceride-

enriched high-density lipoprotein.

M. John Chapman et al. Eur Heart J 2010;31:149-164

Published on behalf of the European Society of Cardiology. All rights reserved. © The Author 2009. For permissions please email: journals.permissions@oxfordjournals.org

Cardiovascular risk remains high despite aggressive statin therapy.

M. John Chapman et al. Eur Heart J 2010;31:149-164

Published on behalf of the European Society of Cardiology. All rights reserved. © The Author 2009. For permissions please email: journals.permissions@oxfordjournals.org